Lymphedema Terminated Phase 1 / 2 Trials for Hyaluronidase (human recombinant) (DB06205)

Also known as: Lymohedema / Lymphoedema / Lymphoedemas / Lymphoedema NOS

IndicationStatusPhase
DBCOND0029071 (Lymphedema)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01928030Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With CancerSupportive Care